"Why the lack of interest in buying a piece of the new AHZ, now AVH?"
Management Form.
The name might have changed, but they still lack funding certainty.
'Just another couple of years', has been the mantra for to long.
Investors just see another product being touted as the company maker, just like the patch was, just like the vax was .....
Money invested here has been money lost.
What is really different this time?
New AVR detailed research report with valuations, page-16
Add to My Watchlist
What is My Watchlist?
